m
NRNPd6675dMIDTERMdEXAMd(YEARd2022d–
d100/100dPOINTS)dLATESTdUPDATE
1. Whichdofdthedfollowingdaredriskdfactorsdfordneurolepticdmalignantdsyndrome?dSelec
tdalld thatdapplydAge
Rapidddosed escalation
Parentaldroutedofdadministrationd Hig
herdpotencydtypicaldantipsychotics
2. AntipsychoticdmedicationsdprovidedD2dblockadedindthedmesocorticaldpathwaydcausi
ngd whichdofdthedfollowingdeffects?
Reducesdnegativedsymptoms
Increasesdextradpyramidaldsymptoms
d (EPS)dCausesdprolactinemia
Reducesdpositivedsymptoms
3. Phencyclidined(PCP)danddKetaminedexertdtheirduniquedbehavioraldeffectsdbydblock
ingd whichdofdthedfollowingdreceptors?
GABAdtyp
ed recepto
rs
NRNPd6675dMIDTERMdEXAMd(YEARd2022d–
d100/100dPOINTS)dLATESTdUPDATE
about:blank 1/59
,10/19/23,d2:09dPM Nrnpd6675d15dweekd6dmidtermdexa
m
Serotonin
d receptors
NRNPd6675dMIDTERMdEXAMd(YEARd2022d–
d100/100dPOINTS)dLATESTdUPDATE
about:blank 2/59
,10/19/23,d2:09dPM Nrnpd6675d15dweekd6dmidtermdexa
m
Dopaminedreceptorsd
NMDAdtypedreceptors
4. Theddiagnosisduseddtoddescribedadsyndromedcharacterizeddbydspecificdsignsdandd sy
mptomsdresultingdfromdrecentdingestiondordexposuredtodadsubstancedisdknowndasdwhi
chd ofdthedfollowing?
Substanced intoxicat
iond Substanced wit
hdrawald Substance
dused disorderdAnyd
ofdthed above
fi.d Abnormaldinvoluntarydmovementsdindadrhythmicdpatterndaffectingdface,dmouth,dtongu
e,d jawdisdknowndasdwhichdofdthedfollowing?
Akathisi
d ad Dys
tonid a
NRNPd6675dMIDTERMdEXAMd(YEARd2022d–
d100/100dPOINTS)dLATESTdUPDATE
about:blank 3/59
, 10/19/23,d2:09dPM Nrnpd6675d15dweekd6dmidtermdexa
m
Tardiveddyskinesia
d Extrapyramidaldsi
ded effects
6.d Addeeplydhelddbeliefddespitedevidencedtodthedcontrary,dlastingdatdleastdonedmonth,dwithoutd pr
ominentdhallucinations,dwithdfunctionaldimpairmentdthatdrelatesdtodtheddelusionaldsyste.....
Schizophrenia
Delusionalddisorderd
Briefdpsychoticd disor
der
Schizophreniformd disorder
NRNPd6675dMIDTERMdEXAMd(YEARd2022d–
d100/100dPOINTS)dLATESTdUPDATE
about:blank 4/59